[
  {
    "ts": null,
    "headline": "Labcorp Holdings (LH) Launches CE-Marked Test for Cancer Care Expansion in EU",
    "summary": "Labcorp Holdings (LH) has recently celebrated a significant milestone with the CE-marking approval of its PGDx elio tissue complete test in the EU, a breakthrough that enhances access to personalized cancer care. This achievement, alongside the announcement of a $0.72 dividend per share and solid Q2 financial results, likely supported the company's 8.93% price increase over the last quarter. Additionally, Labcorp’s aggressive share buyback program and strategic client partnerships may have...",
    "url": "https://finnhub.io/api/news?id=015712680b8a24a1f969affbb342b32c9743212f79d769942fab1fbdcd6eae82",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753809603,
      "headline": "Labcorp Holdings (LH) Launches CE-Marked Test for Cancer Care Expansion in EU",
      "id": 136119809,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LH",
      "source": "Yahoo",
      "summary": "Labcorp Holdings (LH) has recently celebrated a significant milestone with the CE-marking approval of its PGDx elio tissue complete test in the EU, a breakthrough that enhances access to personalized cancer care. This achievement, alongside the announcement of a $0.72 dividend per share and solid Q2 financial results, likely supported the company's 8.93% price increase over the last quarter. Additionally, Labcorp’s aggressive share buyback program and strategic client partnerships may have...",
      "url": "https://finnhub.io/api/news?id=015712680b8a24a1f969affbb342b32c9743212f79d769942fab1fbdcd6eae82"
    }
  },
  {
    "ts": null,
    "headline": "Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term",
    "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
    "url": "https://finnhub.io/api/news?id=4be421f368244a8396805a1e572804a9f7285495e19ba173a0bdd3f8b3e6a80c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753796403,
      "headline": "Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term",
      "id": 136119810,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LH",
      "source": "Yahoo",
      "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
      "url": "https://finnhub.io/api/news?id=4be421f368244a8396805a1e572804a9f7285495e19ba173a0bdd3f8b3e6a80c"
    }
  },
  {
    "ts": null,
    "headline": "Quest, Labcorp downplay ‘Big Beautiful Bill’ impact",
    "summary": "Executives at the laboratory companies said they expect the effects on testing services from the Republicans’ tax and domestic policy bill, including cuts to Medicaid, will be minimal.",
    "url": "https://finnhub.io/api/news?id=77ed8e4fa3168e7875be7902abe04404db0bb3065396a49766a010449c9ff653",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753790409,
      "headline": "Quest, Labcorp downplay ‘Big Beautiful Bill’ impact",
      "id": 136119811,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LH",
      "source": "Yahoo",
      "summary": "Executives at the laboratory companies said they expect the effects on testing services from the Republicans’ tax and domestic policy bill, including cuts to Medicaid, will be minimal.",
      "url": "https://finnhub.io/api/news?id=77ed8e4fa3168e7875be7902abe04404db0bb3065396a49766a010449c9ff653"
    }
  },
  {
    "ts": null,
    "headline": "Labcorp Achieves IVDR CE-Marking for PGDx elio™ tissue complete in the EU",
    "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today PGDx elio™ tissue complete has been CE-marked under the European Union's (EU) new In Vitro Diagnostic Regulation (IVDR). It is now the first and only test of its kind in the EU CE-marked for comprehensive solid tumor profiling. This marks a significant milestone in expanding access to personalized treatment options for the approximately 2.7 million people diagnosed with cancer every year in t",
    "url": "https://finnhub.io/api/news?id=12bc0eadee1dbd9b3bf6f2e57e6d890a0eb49ddfdd826ba0f9a3ec5f7f0fb332",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753786800,
      "headline": "Labcorp Achieves IVDR CE-Marking for PGDx elio™ tissue complete in the EU",
      "id": 136117381,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LH",
      "source": "Yahoo",
      "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today PGDx elio™ tissue complete has been CE-marked under the European Union's (EU) new In Vitro Diagnostic Regulation (IVDR). It is now the first and only test of its kind in the EU CE-marked for comprehensive solid tumor profiling. This marks a significant milestone in expanding access to personalized treatment options for the approximately 2.7 million people diagnosed with cancer every year in t",
      "url": "https://finnhub.io/api/news?id=12bc0eadee1dbd9b3bf6f2e57e6d890a0eb49ddfdd826ba0f9a3ec5f7f0fb332"
    }
  }
]